Skip to content

The effect of melatonin on pediateric drug resistant epilepcy

The effect of melatonin on pediateric drug resistant epilepcy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016100730187N1
Enrollment
32
Registered
2016-10-22
Start date
2012-03-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable epilepsy. Epilepsy

Interventions

Intervention group: Melatonin at a rate of 10 mg /m2 was given 30 minutes before bedtime and then after 24 hours placebo administered..
Treatment - Drugs
Intervention group: Melatonin at a rate of 10 mg /m2 was given 30 minutes before bedtime and then after 24 hours placebo administered.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 15 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age in pediatrics' range between 1 to 15 years old; failure of at least 3 different antiepileptic drugs to control seizures; therapeutic stability for at least 1 month prior to the study, and 4 seizures or more in the last month prior to the initiation of the study. Exclusion criteria: history of neurodegenerative disorders syndromes, cardiovascular anomalies, liver and kidney dysfunction; history of pseudo seizures, seizures with so large numbers and variety that were uncountable; history of status or progressive seizure attack.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Parents’ satisfaction from drug. Timepoint: 2 sets of each 4 week. Method of measurement: spicial forms that complete with parents.;Parents' satisfaction from Sleep. Timepoint: 2 sets of each 4 week. Method of measurement: spicial forms that complete with parents.;Seizures frequency. Timepoint: 2 sets of each 4 week. Method of measurement: spicial forms that complete with parents.;Duration of every seizure. Timepoint: 2 sets of each 4 week. Method of measurement: spicial forms that complete with parents.

Secondary

MeasureTime frame
Plasma melatonin level. Timepoint: brfore and after melatonin administration. Method of measurement: blood sample.;Plasma levels of antiepileptic drugs. Timepoint: before and after melatonin administration. Method of measurement: blood sample.;Side effects. Timepoint: During the study within 8 weeks. Method of measurement: question from parants.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh Talebi

Mashhad University of Medical Sciences

talebis2@mums.ac.ir; quaem.medical.center@mums.ac.ir+98 51 3840 0001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026